Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimens (minitransplants)

Urs Schanz

doi:10.4414/smw.2001.09661

Minireview

Vol. 131 No. 0506 (2001)

Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimens (minitransplants)

Urs Schanz

Fulltext PDF

DOI: https://doi.org/10.4414/smw.2001.09661
Cite this as:: Swiss Med Wkly. 2001;131:59-64
Published: 10.02.2001

How to Cite

1.

Schanz U. Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning regimens (minitransplants). Swiss Med Wkly [Internet]. 2001 Feb. 10 [cited 2024 Nov. 21];131(0506):59-64. Available from: https://smw.ch/index.php/smw/article/view/23

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST), Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016 , Swiss Medical Weekly: Vol. 148 No. 0910 (2018)
Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R. Passweg, Yves Chalandon, Swiss Stem Cell Transplantation Group (SBST), Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs , Swiss Medical Weekly: Vol. 154 No. 5 (2024)
Jakob Passweg, Helen Baldomero, Mario Bargetzi, Christoph Bucher, Yves Chalandon, Michel A. Duchosal, Alois Gratwohl, Tayfun Güngör, Urs Hess, Kurt Leibundgut, Grazia Nicoloso de Faveri, Hulya Ozsahin, Thomas Pabst, Christoph Renner, Martin Stern, Georg Stussi, Urs Schanz, for the SBST (Swiss Blood Stem Cell Transplantation Group), Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries , Swiss Medical Weekly: Vol. 143 No. 0708 (2013)
Bernhard Gerber, Jan Köppel, Michaela Paul, Thi Dan Linh Nguyen-Kim, Thomas Frauenfelder, Gayathri Nair, Urs Schanz, Markus G. Manz, Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: A real-world, retrospective comparative single-centre study , Swiss Medical Weekly: Vol. 144 No. 2930 (2014)
Alexander Imhof, Dominik J. Schaer, Urs Schwarz, Urs Schanz, Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring , Swiss Medical Weekly: Vol. 136 No. 4546 (2006)
Panagiotis Samaras, Dimitrios Zardavas, Ulf Petrausch, Elefteri Marcel Buset, Sarah R. Haile, Hanspeter Honegger, Raffaele Daniele Siciliano, Urs Schanz, Axel Mischo, Niklaus G. Schäfer, Christian Taverna, Alexander Knuth, Rolf Stahel, Christoph Renner, Frank Stenner-Liewen, Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)